D

Dhg Pharmaceutical Joint-Stock Co
VN:DHG

Watchlist Manager
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Watchlist
Price: 105 100 VND -0.66% Market Closed
Market Cap: 13.7T VND
Have any thoughts about
Dhg Pharmaceutical Joint-Stock Co?
Write Note

P/E
Price to Earnings

17.1
Current
15.8
Median
21.8
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
17.1
=
Market Cap
13.7T VND
/
Net Income
804.1B VND
All Countries
Close
Earnings Growth PEG
VN
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Average P/E: 30.7
17.1
1%
17.1
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
88.9
76%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29.7
23%
1.3
US
Johnson & Johnson
NYSE:JNJ
23.8
-8%
N/A
US
Merck & Co Inc
NYSE:MRK
20.8
320%
0.1
CH
Roche Holding AG
SIX:ROG
17.6
15%
1.2
UK
AstraZeneca PLC
LSE:AZN
31.7
40%
0.8
CH
Novartis AG
SIX:NOVN
10.9
9%
1.2
US
Pfizer Inc
NYSE:PFE
35.5
102%
0.3

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
15.2
2-Years Forward
P/E
14.1
3-Years Forward
P/E
13.3

See Also

Discover More